InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
ODN 2216 - TLR9 ligand | Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced ... | 2020 | Sci Rep. | Janovec V. et al. | DOI: 10.1038/s41598-020-69614-7 |
ODN 2006 (ODN 7909) | Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced ... | 2020 | Sci Rep. | Janovec V. et al. | DOI: 10.1038/s41598-020-69614-7 |
CL413 VacciGrade™ | Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced ... | 2020 | Sci Rep. | Janovec V. et al. | DOI: 10.1038/s41598-020-69614-7 |
Adilipoline™ (CL413) | Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced ... | 2020 | Sci Rep. | Janovec V. et al. | DOI: 10.1038/s41598-020-69614-7 |
CL264 | Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced ... | 2020 | Sci Rep. | Janovec V. et al. | DOI: 10.1038/s41598-020-69614-7 |
IFA | Synthetic mycobacterial molecular patterns partially complete Freund's adjuvant. | 2020 | Sci Rep. | Dubé JY. et al. | DOI: 10.1038/s41598-020-62543-5 |
CFA | Synthetic mycobacterial molecular patterns partially complete Freund's adjuvant. | 2020 | Sci Rep. | Dubé JY. et al. | DOI: 10.1038/s41598-020-62543-5 |
EndoFit™ OVA protein | Synthetic mycobacterial molecular patterns partially complete Freund's adjuvant. | 2020 | Sci Rep. | Dubé JY. et al. | DOI: 10.1038/s41598-020-62543-5 |
MDP | Synthetic mycobacterial molecular patterns partially complete Freund's adjuvant. | 2020 | Sci Rep. | Dubé JY. et al. | DOI: 10.1038/s41598-020-62543-5 |
Anti-HLA Class I Control | A more efficient preparation system for HLA-eliminated platelets. | 2020 | Vox Sang. | Hayashi T et al. | DOI: 10.1111/vox.12859 |
Anti-HLA Class II Control | A more efficient preparation system for HLA-eliminated platelets. | 2020 | Vox Sang. | Hayashi T et al. | DOI: 10.1111/vox.12859 |
AddaVax™ | A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS. | 2020 | Cell | Dai L. et al. | DOI: 10.1016/j.cell.2020.06.035. |
R848 (Resiquimod) | Impact of mRNA chemistry and manufacturing process on innate immune activation. | 2020 | Sci Adv. | Nelson J. et al. | DOI: 10.1126/sciadv.aaz6893 |
Zeocin® | Impact of mRNA chemistry and manufacturing process on innate immune activation. | 2020 | Sci Adv. | Nelson J. et al. | DOI: 10.1126/sciadv.aaz6893 |
THP1-Dual™ KO-MyD88 Cells | Impact of mRNA chemistry and manufacturing process on innate immune activation. | 2020 | Sci Adv. | Nelson J. et al. | DOI: 10.1126/sciadv.aaz6893 |
A549-Dual™ KO-RIG-I Cells | Impact of mRNA chemistry and manufacturing process on innate immune activation. | 2020 | Sci Adv. | Nelson J. et al. | DOI: 10.1126/sciadv.aaz6893 |
A549-Dual™ Cells | Impact of mRNA chemistry and manufacturing process on innate immune activation. | 2020 | Sci Adv. | Nelson J. et al. | DOI: 10.1126/sciadv.aaz6893 |
5'ppp-dsRNA | Impact of mRNA chemistry and manufacturing process on innate immune activation. | 2020 | Sci Adv. | Nelson J. et al. | DOI: 10.1126/sciadv.aaz6893 |
QUANTI-Blue™ | Impact of mRNA chemistry and manufacturing process on innate immune activation. | 2020 | Sci Adv. | Nelson J. et al. | DOI: 10.1126/sciadv.aaz6893 |
3p-hpRNA - RIG-I agonist | Impact of mRNA chemistry and manufacturing process on innate immune activation. | 2020 | Sci Adv. | Nelson J. et al. | DOI: 10.1126/sciadv.aaz6893 |